Novartis puts up $1B to partner with PTC Therapeutics

The latest stories trending on MedCity News.

Editor's Pick

Top Story Novartis Tries Again in Huntington's, Putting Up $1B to Partner on a PTC Therapeutics Drug Novartis is securing global rights to a PTC Therapeutics Huntington's disease drug candidate that has encouraging Phase 2 data that will be discussed with the FDA to plan a pivotal study. Last year, Novartis discontinued its Huntington's program after safety issues emerged in Phase 2 testing. Sponsored Could GLP-1 Drugs Be Included In Health Coverage? Presented by Personify Health In this new episode of the MedCity Pivot Podcast, Chief Medical Officer Jeff Jacques offers a window into companies' strategies for including GLP-1 drugs in their health benefits. Get The Full Episode Here

Featured News

3 Innovations Philips Is Showcasing at RSNA 2024 Philips is showcasing its partnerships and new products at RSNA 2024, including an expanded collaboration with AWS and a CT scanner that the company said uses up to 80% less radiation than traditional systems. 4 Key Insights into Payer and Provider Leaders' Vision for AI In a recent report, Define Ventures revealed key insights from payers and providers on how they're shaping their AI strategies. Applied Therapeutics Drug Is Denied FDA Approval in Rare Inherited Metabolic Disease The FDA cited deficiencies in govorestat's application in galactosemia, a rare metabolic disease, Applied Therapeutics said. The biotech is still on track to submit a separate application for the drug in sorbitol dehydrogenase (SORD) deficiency, another rare disease that has no FDA-approved therapies. Tackling Burnout: How AI Lifts the Coding Burden on Physicians Besides the impact to physician satisfaction, the cost of this administrative burden is staggering: Organizations spend $82.7 billion annually on documentation, coding, and other administrative tasks, straining both budgets and staff. A New Perspective on Suicide: It's More Than Just Depression It's about interpreting the full range of factors, from biology to life circumstances, that can push someone to the edge.

Resources

MedCity FemFwd: How Doulas Can Improve Maternal Health Outcomes In this episode, we're joined by Dr. Tiffany Inglis, national medical director for women and children's health at Carelon Health, a subsidiary of Elevance Health. Inglis discusses a paper Elevance Health Public Policy Institute recently published about doulas. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe